Ποια είναι η τιμή για Laboratorio Reig Jofre, S.A. (RJF)

Η τιμή για Laboratorio Reig Jofre, S.A. (RJF) είναι $3.20

Ποια είναι η κεφαλαιοποίηση αγοράς για Laboratorio Reig Jofre, S.A. (RJF)

Η κεφαλαιοποίηση αγοράς για Laboratorio Reig Jofre, S.A. (RJF) είναι $262.86M

Laboratorio Reig Jofre, S.A. (RJF) Τιμή και Κεφαλαιοποίηση Αγοράς

Laboratorio Reig Jofre, S.A. is a pharmaceutical company dedicated to the research, development, manufacturing, and commercialization of a diverse range of medicines and nutritional supplements. Its extensive portfolio encompasses prescription drugs, over-the-counter (OTC) products, medical devices, and cosmetics. The company's offerings are categorized into several key areas: advanced pharmaceutical technologies, which include antibiotics and injectable formulations; specialized healthcare solutions targeting dermatological, musculoskeletal (joint health and pain), women's health, respiratory/ENT, and pediatric needs; and consumer health items marketed under its Forté Pharma brand. Furthermore, Laboratorio Reig Jofre provides contract development and manufacturing (CDMO) as well as contract manufacturing organization (CMO) services. Founded in 1929 and headquartered in Sant Joan Despí, Spain, the company sells its products directly in seven countries and collaborates with business partners to reach approximately 70 other nations. It operates as a subsidiary of Reig Jofre Investments SL.

Η τιμή για RJF	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$64,082.36 $262.86M	NVDA	$5.260T	+2,000,836.24%
$58,220.97 $262.86M	AAPL	$4.779T	+1,817,817.55%
$48,939.42 $262.86M	GOOG	$4.017T	+1,528,006.31%
$45,315.56 $262.86M	MSFT	$3.719T	+1,414,853.15%
$33,313.60 $262.86M	AMZN	$2.734T	+1,040,098.74%

Η τιμή για RJF

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$64,082.36 $262.86M